Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
5
×
life sciences
national blog main
san francisco
5
×
san francisco blog main
5
×
san francisco top stories
biotech
boston blog main
boston top stories
cancer
investing
national top stories
new york blog main
startups
10x genomics
clinical trials
medical device
medical devices
new york top stories
raleigh-durham blog main
roche
san diego blog main
seattle blog main
seattle top stories
accelerator
airbnb
alphabet
amazon web services (aws)
amgen
artificial intelligence (a.i.)
astellas pharma
athelas
atomwise
becton dickinson
benchling
biotech ipos
biotechnology
broad institute of harvard and mit
brook byers
cancer diagnostics
What
big
companies
diagnostics
ipo
life
adding
admits
ago
aims
available
based
bio
biosciences
biotech
biotechs
boost
cancer
cas
cheaper
classes
combinator
company
crispr
deal
decisions
despite
develop
diagnostic
drug
dug
expand
expects
family
faster
fold
followed
genomics
hardest
haul
help
Language
unset
5
×
Current search:
deals
×
" san francisco blog main "
×
" san francisco "
×
unset
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
